Lauren Barker, OD
Optometrist · Dover, OHNPI 1427632637
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $224 and has fallen 79.5% since, to $46 in 2025. That places this record below the midpoint for optometrist clinicians in OH, where the typical reported total is $701.
Across 27 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$112
- Johnson & Johnson Vision Care, Inc.$107
- Bausch & Lomb Americas Inc.$95
- Coopervision Inc.$72
- Dompe US, Inc.$43
- Tarsus Pharmaceuticals, Inc.$40
- plus $109 from 5 others
What the payments were for
- Food & beverage$55997%
- Entertainment$203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $112 |
| Johnson & Johnson Vision Care, Inc. | 5 | $107 |
| Bausch & Lomb Americas Inc. | 1 | $95 |
| Coopervision Inc. | 4 | $72 |
| Dompe US, Inc. | 2 | $43 |
| Tarsus Pharmaceuticals, Inc. | 2 | $40 |
| Plexus Optix, Inc. | 1 | $35 |
| Novartis | 1 | $21 |
| Biotissue Holdings Inc. | 1 | $21 |
| Optos, Inc. | 1 | $20 |
| Kala Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$579 in reported general payments places this provider in the 45th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Restasis MultidoseCyclosporine | 13 | $8,059 |
| Prednisolone Acetate | 21 | $473 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $379 |
| Latanoprost | 39 | $302 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Dover
- Scott KeatingDover$20K
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
- Carly RoseCincinnati$203K
- Wendy HallierReynoldsburg$200K
- John LahrCincinnati$145K
- Erin RueffColumbus$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.